America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Essential financial guidance tailored for young adults to establish solid budgeting and saving foundations from the start.
15,700 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Cathie Wood's bold bets launched a new era for ETFs. This piece explains how ARK helped fuel demand for active ETFs, ...
The crypto market kicked off 2026 with volatility, but three tokens jumped 25% or more. Dive into what drove these ga...
Geopolitics can shake travel stocks fast. This article breaks down how Carnival, the world’s largest cruise operator,...
The U.S. federal debt surpassed $39 trillion for the first time, signaling a turning point for budgeting and markets....
New York Fed researchers find a widening gap in how households respond to rising gas prices after the Iran-related sh...
A deep-dive look at electroCore's 2026 earnings narrative. This article unpacks Q1 signals, growth drivers, and pract...
In April, nebius group stock popped as investors weighed cloud and AI catalysts. This piece breaks down the drivers, ...
Lenders are elevating policy input to combat regulatory volatility, integrating advocacy into strategy. This movement...
As PacBio lays out its Q1 2026 results, investors hunt for catalysts, cadence, and cash runway signals. This guide tr...
Ford is tilting its model lineup toward affordability as CEO Jim Farley emphasizes simpler trims, hybrids, and scalab...
Rivian shares have faced a meaningful pullback, leaving many investors wondering if the rivian stock dip? creates a b...